🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 13 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/05/2016 17,79 18,62 17,31 17,63 -0,40% 7,36% 5.025.600
06/05/2016 16,57 18,25 16,05 17,70 +5,61% 13,28% 7.040.900
05/05/2016 16,94 18,02 15,83 16,76 -2,67% 12,93% 10.315.800
04/05/2016 17,73 18,36 16,62 17,22 -4,44% 9,81% 8.796.300
03/05/2016 18,32 19,84 17,65 18,02 +0,56% 11,95% 27.855.500
02/05/2016 14,83 18,14 14,52 17,92 +26,29% 24,41% 21.882.500
29/04/2016 13,77 15,13 13,70 14,19 +2,83% 10,38% 10.368.700
28/04/2016 13,73 15,38 13,25 13,80 +19,48% 15,51% 25.274.200
27/04/2016 11,09 11,80 10,45 11,55 +4,81% 12,17% 13.369.600
26/04/2016 8,06 11,56 8,00 11,02 -26,29% 44,17% 48.979.700
25/04/2016 14,95 14,95 14,95 14,95 +0,00% 0,00% 11.800
22/04/2016 11,41 15,70 11,10 14,95 +35,66% 40,32% 31.322.800
21/04/2016 11,66 12,52 10,50 11,02 -44,09% 17,32% 22.708.100
20/04/2016 20,87 20,95 19,16 19,71 -5,51% 8,58% 4.579.500
19/04/2016 22,25 22,53 20,64 20,86 -7,00% 8,49% 3.228.700
18/04/2016 21,62 23,20 21,00 22,43 +6,30% 10,18% 4.365.500
15/04/2016 22,16 22,48 20,63 21,10 -4,09% 8,35% 3.155.400
14/04/2016 22,59 22,71 21,82 22,00 -1,57% 3,94% 1.563.000
13/04/2016 22,65 23,29 22,19 22,35 -1,11% 4,86% 2.104.600
12/04/2016 22,47 22,72 21,59 22,60 +0,53% 5,03% 1.588.400
11/04/2016 22,70 23,00 22,40 22,48 -0,88% 2,64% 1.385.200
08/04/2016 24,03 24,20 22,37 22,68 -2,58% 7,62% 2.099.100
07/04/2016 22,99 24,60 22,34 23,28 -0,09% 9,83% 5.056.500
06/04/2016 20,96 23,31 20,10 23,30 +19,30% 15,31% 8.594.800
05/04/2016 19,83 20,30 19,51 19,53 -1,71% 3,98% 967.000
04/04/2016 20,19 20,31 19,76 19,87 -0,55% 2,72% 1.350.700
01/04/2016 19,47 20,63 19,20 19,98 +2,36% 7,34% 2.025.800
31/03/2016 19,50 20,10 19,21 19,52 +1,30% 4,56% 1.725.200
30/03/2016 19,46 20,10 18,81 19,27 +0,94% 6,63% 2.237.300
29/03/2016 17,90 19,14 17,61 19,09 +6,29% 8,55% 1.704.500